ODDB.org: Open Drug Database

Mepha Pharma AG - Buprenorphin-Mepha 52.5 ug/h, Transdermale Pflaster

Swissmedic Registration	65809	Sequence	02
Product name	Buprenorphin-Mepha 52.5 ug/h	Description	Transdermale Pflaster
ATC-Classification	N02AE01	ATC-Description	Buprenorphine
Introduction of Sequence	19.05.2015

Composition

buprenorphinum 30 mg, oleylis oleas, povidonum K 90, acidum laevulinicum, acrylates et vinylis acetatis polymerisatum (vernetzt), poly(ethylenis terephthalas), acrylates et vinylis acetatis polymerisatum (nicht vernetzt), Trägermaterial: poly(ethylenis terephthalas), ad praeparationem pro 37.5 cm², cum liberatione 52.5 µg/h.

Packungsbestandteile

Galenic Form

Transdermale Pflaster

Excipiens

Active Agent	Dose
Buprenorphine	30 mg

BAG: Active Agent	Dose
Buprenorphine	30 mg

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
009	4	38.01	57.75	A+	SL	No
010	8	70.49	93.10	A+	SL	No

2025	©ywesee GmbH